Hypoxic dose, intensity distribution, and fatigue monitoring are paramount for "live high-train low" effectiveness

Letter to the editor: Bejder, J., Andersen, A. B., Buchardt, R., Larsson, T. H., Olsen, N. V., & Nordsborg, N. B. (2017). Endurance, aerobic high-intensity, and repeated sprint cycling performance is unaffected by normobaric "Live High-Train Low": a double-blind placebo-controlled cross-over study. European journal of applied physiology, 117(5), 979-988. DOI: https://doi.org/10.1007/s00421-017-3586-0 SPONET: 4068368
© Copyright 2017 European Journal of Applied Physiology. Springer. All rights reserved.

Bibliographic Details
Subjects:
Notations:endurance sports
Published in:European Journal of Applied Physiology
Language:English
Published: 2017
Online Access:https://doi.org/10.1007/s00421-017-3664-3
Volume:117
Issue:10
Pages:2119-2120
Document types:article
Level:advanced